What Is MOTS-c?
MOTS-c is a mitochondrial-derived peptide supplied by Peptegrity for research and educational purposes. This page provides a factual educational overview of MOTS-c, including its classification, biological target, research background, terminology and published study context. It is not a product page and does not provide dosing instructions, treatment recommendations or personal-use guidance.
Type of compound
MOTS-c is a mitochondrial-derived peptide (MDP). It is encoded within the mitochondrial DNA and is categorized as a signaling peptide involved in the regulation of cellular metabolism [1], [2].
Biological target and mechanism
MOTS-c functions by translocating from the mitochondria to the nucleus to regulate gene expression related to metabolic processes. It has been observed to modulate signaling pathways, such as the TGF-β/Smad pathway, and influence factors involved in muscle and bone metabolism [3], [4], [5].
Research background
Research into MOTS-c originated from investigations into mitochondrial biology and the identification of small peptides encoded by the mitochondrial genome. Studies focus on its potential role in coordinating cellular homeostasis across different tissues, including muscle and adipose tissue [1], [4].
Current research and development status
MOTS-c is currently in the investigational research phase. It is not an approved medication and is strictly limited to laboratory and preclinical research settings.
Published research context
Published literature investigates the role of MOTS-c in metabolic homeostasis, noting its influence on insulin sensitivity and weight management [1], [4]. Further research has explored its effects on bone marrow mesenchymal stem cell differentiation [3], the reduction of muscle atrophy markers [5], and its potential impact on cellular senescence [6].
Relevant terminology
Mitochondrial-derived peptides (MDPs) are a group of small proteins encoded by the mitochondrial genome that function as signaling molecules. They play roles in cellular communication, energy metabolism, and stress response mechanisms.
Storage and handling terminology
Research peptides are typically stored as lyophilized powders in a controlled, refrigerated or frozen environment to maintain structural integrity. Researchers must ensure that the substance is handled in a sterile environment and reconstituted according to specific laboratory protocols using appropriate solvents.
Testing and Certificate of Analysis (COA)
A Certificate of Analysis (COA) is a document issued by quality control laboratories that confirms the purity, identity, and concentration of a research compound. Researchers should review the COA to ensure the peptide meets the required specifications for their specific experimental design, typically verified via techniques like HPLC or mass spectrometry.
Regulatory status
MOTS-c is an investigational compound that has not been evaluated or approved by regulatory bodies such as the FDA or TGA for human therapeutic use. It is strictly designated for legitimate research and laboratory experimental purposes only.
This page is for research and educational purposes only. It is not intended to provide medical advice, dosing instructions, or treatment recommendations, and does not represent any product as approved to diagnose, treat, cure or prevent any disease. Compounds described here may be investigational or unapproved medicines; regulatory status is summarised for information only.
Frequently asked questions
What is MOTS-c?
MOTS-c is a peptide encoded by the mitochondrial genome that acts as a signaling molecule to help regulate various metabolic processes within the cell [1], [2].
How is MOTS-c classified?
It is classified as a mitochondrial-derived peptide (MDP), which is a class of peptides distinct from those encoded by the nuclear genome [2].
What is the regulatory status of MOTS-c?
MOTS-c is an investigational research compound. It is not approved by any regulatory authority for the treatment or prevention of any medical condition.
In what areas is MOTS-c being studied?
Current research is examining its influence on metabolic homeostasis, bone health, muscle physiology, and the delay of cellular senescence in experimental models [1], [3], [5], [6].
References
- 1.The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistancePubMed
- 2.MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitationPubMed
- 3.MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathwayPubMed
- 4.MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolismPubMed
- 5.MOTS-c reduces myostatin and muscle atrophy signalingPubMed
- 6.Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetesPubMed
